Optimization of Elderly Influenza and Pneumococcal Immunization Programs in Beijing, China Using Health Economic Evaluations: A Modeling Study
(1) Background: Currently, residents ≥ 60 and ≥65 years old in Beijing, China, are eligible for free influenza and pneumococcal polysaccharide vaccines (PPSV23), respectively. The present study aimed to assess the cost-effectiveness of current and alternative strategies of dual influenza and PPSV23...
Main Authors: | Zhenfei Pi, Kiyoshi Aoyagi, Kazuhiko Arima, Xiaoliang Wu, Zhaojia Ye, Yawen Jiang |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2023-01-01
|
Series: | Vaccines |
Subjects: | |
Online Access: | https://www.mdpi.com/2076-393X/11/1/161 |
Similar Items
-
Influenza and pneumococcal vaccination: do older people know if they have been vaccinated?
by: Alice Laurence, et al.
Published: (2016-06-01) -
PHARMACOECONOMIC EVALUATION OF INFLUENZA AND PNEUMOCOCCAL VACCINATION IN EMPLOYEES OF THE JOINT STOCK COMPANY "RUSSIAN RAILWAYS" (JSCO "RZD") ON INVESTMENT FOR THE EMPLOYER
by: D. A. Zhukov
Published: (2016-02-01) -
Beliefs, attitudes, and activities of healthcare personnel about influenza and pneumococcal vaccines
by: Fatma Çiftci, et al.
Published: (2018-01-01) -
Impact of COVID-19 Outbreak on Influenza and Pneumococcal Vaccination Uptake: A Multi-Center Retrospective Study
by: Chieh Lan, et al.
Published: (2023-05-01) -
Vaccination of patients with bronchial asthma against influenza and pneumococcal infection
by: A. V. Protasov, et al.
Published: (2019-09-01)